Positive results from the AEGEAN Phase III trial showed that treatment with AstraZeneca’s IMFINZI in combination with neoadjuvant chemotherapy before surgery and as adjuvant monotherapy...
Volastra Therapeutics, a clinical-stage cancer biotechnology company focused on exploiting chromosomal instability (CIN), released preclinical data from the company’s portfolio of KIF18A inhibitors at...
A landmark paper published in The Lancet Neurology journal by leaders of the Parkinson's Progression Markers Initiative (PPMI), the gold-standard Parkinson's biomarker study sponsored by The...
M2GEN, an oncology bioinformatics company with the most advanced lifetime-consented clinicogenomic data to accelerate medical product discovery, announced it is rebranding, changing the company's...
Agena Bioscience and nRichDX have advanced their existing technical collaboration to a commercial partnership that co-promotes their products to researchers developing liquid biopsy applications...
